Sign in
4

Changes in Ownership

Moleculin Biotech, Inc. Filed Acc 0001437749-23-018140

CEO and President gave up 13,697 shares (to pay taxes)

  • CEO and President acquired 56,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
KLEMP WALTER V CEO and President 2023-06-20 Option exercise +56,250 485,052 D
KLEMP WALTER V CEO and President 2023-06-20 Shares withheld for taxes −13,697 $0.57 $7,807 471,355 D
Derivatives
KLEMP WALTER V CEO and President 2023-06-20 Option exercise · Restricted Stock Units −56,250 1,016,691 D
Loading xslF345X04/rdgdoc.xml…